These 3.8 million met the clinical criteria for the Bridge program, did not have a diagnosis of type 2 diabetes, sleep apnea or MASH, did not have a GLP-1 Part D covered prescription in 2023 and "could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026," the report added
*Motley Rice does not represent Ms
However, gastrointestinal reactions also increased accordingly, suggesting a practical trade-off between dose-response and tolerability
So frustrating
If more than four days have passed, skip that dose and resume your next scheduled one Proper administration technique from the first injection makes a big difference in how smoothly the experience goes
To support you further, our team will monitor your progress and make adjustments to your treatment plan as needed